CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome
Syed Shahid Habib1, Mohammad Ibrahim Kurdi, Zohair Al Aseri
1Department of Physiology, College of Medicine & KKUH, King Saud University, Riyadh. shahidhabib44@hotmail.com
Insights
Peak high-sensitivity C-reactive protein (hsCRP) levels are higher in ST-elevation myocardial infarction (STEMI) patients compared to non-ST-elevation myocardial infarction (NSTEMI) patients. This suggests inflammation plays a role in myocardial infarction and hsCRP may aid risk stratification.
Area of Science:
- Cardiology
- Biomarkers
- Inflammation
Background:
- High-sensitivity C-reactive protein (hsCRP) is of significant interest for cardiovascular risk assessment.
- Elevated hsCRP early in acute coronary syndrome (ACS) may indicate underlying cardiovascular comorbidities.
- hsCRP's role in differentiating myocardial infarction subtypes requires further investigation.
Purpose of the Study:
- To investigate serial hsCRP measurements in acute coronary syndrome (ACS) patients.
- To compare hsCRP levels between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients.
Main Methods:
- An observational study involving 89 patients with acute myocardial infarction (AMI).
- Three serial hsCRP measurements were taken: baseline (admission), peak (36-48 hours), and follow-up (4-6 weeks).
- hsCRP levels were compared between STEMI and NSTEMI patient groups.
Main Results:
- STEMI patients exhibited higher Body Mass Index (BMI), Creatine Kinase-Myocardial Bound (CKMB), and Aspartate Aminotransferase (AST) levels compared to NSTEMI patients.
- Baseline and follow-up hsCRP levels did not significantly differ between STEMI and NSTEMI groups.
- Peak hsCRP levels were significantly higher in STEMI patients than in NSTEMI patients (p=0.0464).
Conclusions:
- STEMI patients demonstrate significantly elevated peak hsCRP levels compared to NSTEMI patients.
- These findings support the independent role of inflammation in myocardial infarction pathogenesis.
- hsCRP assessment may be a valuable tool for risk stratification post-myocardial infarction.
Background:
There is intense interest in the use of high-sensitivity C-reactive protein (hsCRP) for risk assessment. Elevated hsCRP concentrations early in acute coronary syndrome (ACS), prior to the tissue necrosis, may be a surrogate marker for cardiovascular co-morbidities.
Objective:
Therefore we aimed to study different follow up measurements of hsCRP levels in acute coronary syndrome patients and to compare the difference between non-ST elevation myocardial infarction (NSTEMI) and ST myocardial infarction (STEMI) patients.
Methods:
This is an observational study. Of the 89 patients recruited 60 patients had acute myocardial infarction (AMI). Three serial hsCRP levels at baseline on admission to hospital before 12 hours of symptom onset, peak levels at 36-48 hours and follow up levels after 4-6 weeks were analyzed and compared between non-ST elevation AMI and ST elevation AMI.
Results:
STEMI patients had significantly higher BMI compared to NSTEMI patients. Creatine kinase myocardial bound (CKMB) and Aspartate aminotransferase (AST) levels were significantly higher in STEMI patients compared to NSTEMI patients (p<0.05). CRP levels at baseline and at follow up did not significantly differ between the two groups (p = 0.2152, p = 0.4686 respectively). There was a significant difference regarding peak CRP levels between the two groups, as STEMI patients had significantly higher peak CRP levels compared to NSTEMI patients (p = 0.0464).
Conclusion:
STEMI patients have significantly higher peak CRP levels compared to NSTEMI patients. These data suggest that inflammatory processes play an independent role in the pathogenesis of myocardial infarction. Thus, CRP assessment may assist in risk stratification after myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome IV: Interprofessional Care
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

